Test Price
2,800 AED✅ Home Collection Available
SFTPA2 Gene Idiopathic Pulmonary Fibrosis Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Accuracy Guarantee
99.9% diagnostic sensitivity via ISO 9001:2015 accredited NGS processing (Cert: INT/EGQ/2509DA/3139).
Premium Logistics
VIP Mobile Phlebotomy and temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM.
Clinical Guidance
Telephonic post-test clinical guidance for result interpretation provided by our genetic counsellors.
Insurance
Direct billing verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The SFTPA2 genetic test uses next-generation sequencing to detect mutations in the surfactant protein A2 gene, which cause familial idiopathic pulmonary fibrosis (IPF). This test empowers early risk assessment and family planning, processed in our DHA-compliant, ISO-certified laboratory.
| Feature | Our Test (NGS) | Closest Alternative (Targeted Mutation) |
|---|---|---|
| Methodology | Full-gene next-generation sequencing with Sanger confirmation | PCR-based hotspot analysis (limited exons) |
| Detection Rate | >99.9% of all known pathogenic variants | ~80% (misses rare or novel mutations) |
| Turnaround Time | 3–4 Weeks | 2–3 Weeks |
| Sample Requirement | Whole blood, extracted DNA, or FTA card blood spot | Whole blood or extracted DNA only |
| Clinical Utility | Comprehensive risk assessment, family screening, research | Basic screening for common mutations |
Physician Insight & Safety Protocols
"A genetic test result for SFTPA2 must never be interpreted in isolation. Correlation with pulmonary function tests, high-resolution CT imaging, and a detailed three-generation family pedigree is essential. Patients should always receive post-test genetic counselling before making any medical decisions." — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403.
Medication Advisory
Do Not Alter Medications Without Medical Consultation
Do not discontinue or adjust any prescribed therapy, particularly corticosteroids or antifibrotic agents such as pirfenidone or nintedanib, based solely on genetic test results. Always consult your treating pulmonologist before making changes.
Exclusion Criteria & Emergency Red Flags
- This test is not a substitute for lung biopsy or a clinical diagnosis of active idiopathic pulmonary fibrosis.
- Not offered to minors without court-approved consent as per UAE Federal Law.
- Individuals experiencing acute respiratory distress, unexplained hemoptysis, or sudden chest pain should seek immediate emergency care — contact 998 (UAE Ambulance).
- Pregnancy or planning for prenatal diagnosis requires separate genetic counselling both before and after testing.
Patient FAQ & Clinical Guidance
1. What is the SFTPA2 genetic test and who should consider it?
The SFTPA2 genetic test uses next-generation sequencing to detect mutations in the surfactant protein A2 gene that cause familial idiopathic pulmonary fibrosis. It is recommended for individuals with a first-degree relative diagnosed with IPF, adults with early-onset unexplained interstitial lung disease, and those seeking reproductive risk assessment after genetic counselling.
2. How is the sample collected and what is the turnaround time?
A blood sample, extracted DNA, or FTA card blood spot is collected by our certified phlebotomist at your home between 8 AM and 11 PM. The specimen is transported via cold chain to our ISO-accredited laboratory. Results are reported within 3 to 4 weeks and delivered through a secure digital portal.
3. What do the results mean and how are they interpreted?
A positive result identifies a pathogenic SFTPA2 mutation indicating elevated risk for pulmonary fibrosis, requiring clinical correlation and family screening. A negative result reduces but does not eliminate IPF risk. Variants of uncertain significance may require additional family studies. Our genetic counsellors provide a dedicated consultation to explain your report in full clinical context.
4. What preparations are needed before the test?
A clinical history documenting IPF symptoms or family history is recommended. A pre-test genetic counselling session to construct a three-generation pedigree is strongly advised. No fasting is required. If you are taking anticoagulants, please inform our phlebotomist before collection.
UAE Regulatory & Data Privacy Adherence
All genetic data processing, storage, and transmission comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Your genomic data is encrypted and accessible only by authorised medical professionals.
Clinical & Logistical Metadata
| Test Name | SFTPA2 Gene Idiopathic Pulmonary Fibrosis Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood, Extracted DNA, or FTA Card Blood Spot |
| Methodology Used | Full-Gene Next-Generation Sequencing with Sanger Confirmation |
| ICD-10-CM Code | J84.112, Z13.83 |
| LOINC Code | 91854-8 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians